SI-BONE, Inc. (SIBN)

Market Cap	628.29M
Revenue (ttm)	138.89M
Net Income (ttm)	-43.34M
Shares Out	41.06M
EPS (ttm)	-1.13
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	289,416
Open	15.24
Previous Close	15.23
Day's Range	15.04 - 15.39
52-Week Range	14.84 - 29.51
Beta	1.22
Analysts	Strong Buy
Price Target	26.50 (+73.2%)
Earnings Date	May 6, 2024

About SIBN

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; i...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Oct 17, 2018
• Employees: 344
• Stock Exchange: NASDAQ
• Ticker Symbol: SIBN

Financial Performance

In 2023, SI-BONE's revenue was $138.89 million, an increase of 30.52% compared to the previous year's $106.41 million. Losses were -$43.34 million, -29.25% less than in 2022.

Analyst Forecast

According to 8 analysts, the average rating for SIBN stock is "Strong Buy." The 12-month stock price forecast is $26.5, which is an increase of 73.20% from the latest price.

Price Target

$26.5

(73.20% upside)

Analyst Consensus: Strong Buy